当前位置: X-MOL 学术Theranostics › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways
Theranostics ( IF 12.4 ) Pub Date : 2018-02-07 , DOI: 10.7150/thno.22699
Nan Mu , Jintao Gu , Nannan Liu , Xiaochang Xue , Zhen Shu , Kuo Zhang , Tonglie Huang , Chu Chu , Wangqian Zhang , Li Gong , Huadong Zhao , Bo Jia , Dakuan Gao , Lei Shang , Wei Zhang , Qingdong Guo

Purpose: Glioblastoma is the most common and aggressive type of primary brain malignancy and is associated with a poor prognosis. Previously, we found that phosphatase of regenerating liver-3 (PRL-3) was significantly up-regulated in glioblastoma as determined by a microarray analysis. However, the function of PRL-3 in glioblastoma remains unknown. We aimed to investigate the clinical relationship between PRL-3 and glioblastoma, and uncover the mechanisms of PRL-3 in the process of glioblastoma.

中文翻译:

PRL-3是潜在的胶质母细胞瘤预后标志物,并通过ERK和JNK途径增强MMP7来促进胶质母细胞瘤进展

目的:胶质母细胞瘤是原发性脑恶性肿瘤中最常见和最具侵略性的类型,其预后不良。以前,我们发现胶质母细胞瘤中再生肝3(PRL-3)的磷酸酶显着上调,这是通过微阵列分析确定的。但是,PRL-3在胶质母细胞瘤中的功能仍然未知。目的探讨PRL-3与胶质母细胞瘤的临床关系,揭示PRL-3在胶质母细胞瘤过程中的作用机制。
更新日期:2018-06-01
down
wechat
bug